Active Ingredient: ZILEUTON
Proprietary Name: ZILEUTON
Dosage Form; Route of Administration: TABLET, EXTENDED RELEASE; ORAL
Strength: 600MG
Reference Listed Drug: No
Reference Standard: No
TE Code:
Application Number: A211043
Product Number: 001
Approval Date: May 3, 2022
Applicant Holder Full Name: TEVA PHARMACEUTICALS USA INC
Marketing Status:
Discontinued
Patent and Exclusivity Information